These results may add further explanation of our previous observation that sCD163 concentration increases with deteriorating glycemic control in BMI-matched groups of subjects with NGT, IGT, and T2DM, and the common observation that the adverse metabolic consequences of obesity vary between individuals. Here, CD163 is linked to obesity due to melanocortin 4 receptor deficiency.